SEC Form 4 · accession 0001209191-17-007910
GigPeak, Inc. · GIG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi S Katz
Officer — President and CEO · Director
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001432150
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2017 | M | 8,050 | $0.00 | A | 209,988 | D | |
| Common StockF2,F3 | Feb 1, 2017 | F | 4,722 | $2.58 | D | 205,266 | D | |
| Common StockF4 | Feb 1, 2017 | M | 19,625 | $0.00 | A | 224,891 | D | |
| Common StockF5,F3 | Feb 1, 2017 | F | 11,511 | $2.58 | D | 213,380 | D | |
| Common StockF6 | Feb 1, 2017 | M | 33,693 | $0.00 | A | 247,073 | D | |
| Common StockF7,F3 | Feb 1, 2017 | F | 18,141 | $2.58 | D | 228,932 | D | |
| Common StockF8,F3 | Feb 1, 2017 | M | 125,000 | $0.00 | A | 353,932 | D | |
| Common StockF9,F3 | Feb 1, 2017 | F | 66,652 | $2.58 | D | 287,280 | D | |
| Common StockF10 | Feb 1, 2017 | M | 66,874 | $0.00 | A | 354,154 | D | |
| Common StockF11,F3 | Feb 1, 2017 | F | 35,678 | $2.58 | D | 318,476 | D | |
| Common StockF12 | Feb 1, 2017 | M | 3,260 | $0.00 | A | 321,736 | D | |
| Common StockF13,F3 | Feb 1, 2017 | F | 1,740 | $2.58 | D | 319,996 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs)F1,F14 | $0.00 | Feb 1, 2017 | M | 8,050 | D | — | — | Common Stock | 8,050 | 16,100 | D |
| Restricted Stock Units (RSUs)F4,F15 | $0.00 | Feb 1, 2017 | M | 19,625 | D | — | — | Common Stock | 19,625 | 117,750 | D |
| Restricted Stock Units (RSUs)F6,F16 | $0.00 | Feb 1, 2017 | M | 33,693 | D | — | — | Common Stock | 33,693 | 303,238 | D |
| Restricted Stock Units (RSUs)F8,F17 | $0.00 | Feb 1, 2017 | M | 125,000 | D | — | — | Common Stock | 125,000 | 375,000 | D |
| Restricted Stock Units (RSUs)F10,F18 | $0.00 | Feb 1, 2017 | M | 66,874 | D | — | — | Common Stock | 66,874 | 200,624 | D |
| Restricted Stock Units (RSUs)F12,F19 | $0.00 | Feb 1, 2017 | M | 3,260 | D | — | — | Common Stock | 3,260 | 29,341 | D |
Explanation of responses
- F18,050 Restricted Stock Units ("RSUs") issued in the grant to Dr. Katz on 8/1/2013 vested on 2/1/2017 according to the vesting schedule previously reported.
- F1066,874 RSUs issued in the grant to Dr. Katz on 7/19/2016 vested on 2/1/2017 according to the vesting schedule previously reported.
- F1135,678 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F123,260 RSUs issued in the grant to Dr. Katz on 7/19/2016 vested on 2/1/2017 according to the vesting schedule previously reported.
- F131,740 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F14The RSUs vest as follows: 25% vested on May 1, 2014. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2014 and ending on May 1, 2017, as previously reported.
- F15The RSUs vest as follows: 25% vested on May 1, 2015. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2015 and ending on May 1, 2018, as previously reported.
- F16The RSUs vest as follows: 25% vested on May 1, 2016. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2016 and ending on May 1, 2019, as previously reported.
- F17The RSUs vest as follows: 25% vested on February 1, 2017. The remaining 75% vest in twelve quarterly installments thereafter, beginning on May 1, 2017 and ending on February 1, 2020.
- F18The RSUs vest in six quarterly installments beginning on August 1, 2016 and ending on November 1, 2017, as previously reported.
- F19The RSUs vest in twelve quarterly installments, beginning on August 1, 2016 and ending on May 1, 2019, as previously reported.
- F24,722 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F3The closing price of the Company's common stock on 2/1/2017.
- F419,625 RSUs issued in the grant to Dr. Katz on 2/10/2014 vested on 2/1/2017 according to the vesting schedule previously reported.
- F511,511 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F633,693 RSUs issued in the grant to Dr. Katz on 3/26/2015 vested on 2/1/2017. As previously disclosed by the Company in its Current Report on Form 8-K, as filed with the SEC on July 20, 2016, and the Form 4 filed by Dr. Katz on that date, 60,106 total unvested RSUs from this award were rescinded on July 19, 2016. This rescission is partially reflected herein.
- F718,141 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F8125,000 RSUs issued in the grant to Dr. Katz on 1/5/2016 vested on 2/1/2017 according to the vesting schedule previously reported.
- F966,652 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.